Market Synopsis of the Global
Biological computers Market
Biological computers, also known as DNA computers,
are microcomputers designed for their use in the field of medicine. This
implantable device can be used for various functions such as monitoring the
activities of the body or inducing therapeutic effects. Hardware, software,
input, and output are the four major components of a biological computer. These
components are made of DNA, RNA and proteins. Biological computers are able to
perform mathematical calculations that enable the researcher to construct a
system of biosensors. This system of biosensors can detect or target specific
types of cells such as cancer cells in the patient’s body.
Rising prevalence of cancer, and
increasing demand for DNA or gene chips are some of the major factors driving
the growth of this market across the globe. Furthermore, increasing healthcare
expenditure and overall growth of the healthcare industry also influence the
market growth. Splendid research in the field of oncology also boosts the
market.
As per the report of the Centers
for Disease Control and Prevention (CDC), in 2014, over 14.1 million of new
cancer cases were registered worldwide.
The global biological computers
market is expected to grow at a CAGR of 7.1% during the forecast period
2017-2023.
Segments
The global biological computers
market is segmented on the basis of component, application, and end user.
On the basis of the component,
market is segmented into hardware, software, input, and output.
On the basis of the application,
the market is segmented into oncology, molecular genetics, nanobiotechnology,
and others.
On the basis of the end user, the
market is segmented into pharmaceutical & biotechnology companies, research
centers, healthcare it companies, hospital & clinics, and others.
Regional Analysis of the Global
Biological Computers Market
The Americas hold the first
position in the biological computers market owing to the rising prevalence of
cancer in the U.S., and increasing demand for new cancer diagnostic and
treatment services. In the Americas, North America is the largest market owing
to the presence of key players in the healthcare IT industry.
Europe is the second largest
market for biological computers. In Europe, there is an increasing demand for
healthcare IT solutions and extensive research and development activities is
taking place by clinical research and academic institutes for cancer treatment.
According to Cancer Research UK, in 2014, 356,860 new cases of cancer were
reported, including 579 cases of bone cancer.
The market in Asia Pacific is
expected to grow at the fastest pace and is driven by the high prevalence of
chronic disease such as cancer, obesity, diabetes and other. India, China, and
Japan are major contributors to the growth of the market. This growth is
attributed to an increasing demand for technologically advanced medical devices
and accessories such as gene chips for research activities. Availability of
highly qualified medical professionals dedicated to research in biological
systems is also a contributing factor. The various other factors affecting the
growth of the market in Asia Pacific are rising geriatric population, demand
for advanced therapies, government initiatives, and increasing public awareness
about various diseases and the available treatments.
Additionally, healthcare spending
in Asia Pacific expanded in 2016 due to an extension of state healthcare
programs, and the increasing affluence of the population. Organization for
Economic Co-operation and Development (ECOD) stated that growth in India will
remain high at 7.3% in 2017.
The Middle East & Africa also
show a steady rise in the market owing to low technological penetration and
increasing awareness about cancer treatment. In the Middle East & Africa,
Middle East captures the largest market share for biological medicines owing to
the availability of better healthcare infrastructure and wide scope for
research.
Key Players in the Global
Biological computers
Market
Some of the key players in this
market are Microsoft (U.S.), IBM (U.S.), Thermofisher Scientific (U.S.),
Illumina, Inc. (U.S.), IndieBio (U.S.), Emulate Inc. (U.S.), and others. Key
players manufactruing DNA or gene chips are Sequenom Inc., Merck KGaA (U.S.),
Macrogen Corp (Republic of Korea), Bioneer Corporation (Republic of Korea),
Biometrix Technology Inc (U.S.), Wafergen Biosystems Inc. (U.S.), and Eurofins
Genomics India Pvt Ltd. (India).
Apply for Exclusive Discount @
Detailed Table
of Contents:
Table Of Content
1. Report Prologue
2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
...Continued
About US:
Market
Research Future (MRFR), enable customers to unravel the complexity of various
industries through Cooked Research Report (CRR), Half-Cooked Research Reports
(HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market
Research & Consulting Services.
Contact
Us:
Market
Research Future
Office
No. 528, Amanora Chambers
Magarpatta
Road, Hadapsar,
Pune
- 411028
Maharashtra,
India
Phone:
+1 646 845 9312
Email:
sales@marketresearchfuture.com
No comments:
Post a Comment